Since the Yamagata lineage of type B influenza has not circulated since early 2020, experts agree that countries using a quadrivalent influenza vaccine should return to a trivalent one.
No takes yet. Share an insight, caveat, or question.
Monto et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: